Since its inception in 2006, Tobira has raised a total of $72 million from life science investors, including Domain Associates, L.L.C., Frazier Healthcare Ventures, Montreux Equity Partners, Novo A/S and Canaan Partners.
400 Oyster Point Boulevard Suite 525 South San Francisco, CA 94080 +1 (650) 741-6625 www.tobiratherapeutics.com
